Aldeyra Therapeutics ALDX
NASDAQ ALDX
$0.67 -0.06 (-8.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Operating Leases (2019 - 2025)

Updated

Aldeyra Therapeutics' Operating Leases came in at $72,536 for Q3 2025, up 3.3% from $70,234 a year earlier but down 49.4% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Operating Leases (2019 - 2025) Analysis & Trends

At the end of FY2023, Aldeyra Therapeutics' Operating Leases was $271,631.

  • Going back by year, Operating Leases was $125,232 in FY2021.
  • The five-year range for quarterly Operating Leases is $63,325 (Q1 2022) to $271,631 (Q4 2023).
  • Year-over-year, Operating Leases has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Aldeyra Therapeutics 40.82 Mn -214.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 72,536.00
Jun 30, 2025 143,447.00
Mar 31, 2025 212,769.00
Sep 30, 2024 70,234.00
Jun 30, 2024 138,893.00
Mar 31, 2024 206,014.00
Dec 31, 2023 271,631.00
Mar 31, 2022 63,325.00
Dec 31, 2021 125,232.00
Sep 30, 2021 184,599.00
Sep 30, 2019 58,720.00
Jun 30, 2019 116,124.00
Mar 31, 2019 156,808.00
API Access

Aldeyra Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ALDX&period=max&api_key=YOUR_API_KEY